1. Home
  2. CGTX vs GYRO Comparison

CGTX vs GYRO Comparison

Compare CGTX & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • GYRO
  • Stock Information
  • Founded
  • CGTX 2007
  • GYRO 1946
  • Country
  • CGTX United States
  • GYRO United States
  • Employees
  • CGTX N/A
  • GYRO N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • CGTX Health Care
  • GYRO Real Estate
  • Exchange
  • CGTX Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • CGTX 16.1M
  • GYRO 19.2M
  • IPO Year
  • CGTX 2021
  • GYRO N/A
  • Fundamental
  • Price
  • CGTX $0.63
  • GYRO $9.36
  • Analyst Decision
  • CGTX Strong Buy
  • GYRO
  • Analyst Count
  • CGTX 6
  • GYRO 0
  • Target Price
  • CGTX $8.30
  • GYRO N/A
  • AVG Volume (30 Days)
  • CGTX 20.0M
  • GYRO 551.0
  • Earning Date
  • CGTX 11-13-2024
  • GYRO 01-01-0001
  • Dividend Yield
  • CGTX N/A
  • GYRO N/A
  • EPS Growth
  • CGTX N/A
  • GYRO N/A
  • EPS
  • CGTX N/A
  • GYRO N/A
  • Revenue
  • CGTX N/A
  • GYRO $2,738,019.00
  • Revenue This Year
  • CGTX N/A
  • GYRO N/A
  • Revenue Next Year
  • CGTX N/A
  • GYRO N/A
  • P/E Ratio
  • CGTX N/A
  • GYRO N/A
  • Revenue Growth
  • CGTX N/A
  • GYRO N/A
  • 52 Week Low
  • CGTX $0.34
  • GYRO $7.65
  • 52 Week High
  • CGTX $2.95
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 69.18
  • GYRO 46.75
  • Support Level
  • CGTX $0.43
  • GYRO $9.25
  • Resistance Level
  • CGTX $1.29
  • GYRO $9.40
  • Average True Range (ATR)
  • CGTX 0.10
  • GYRO 0.10
  • MACD
  • CGTX 0.03
  • GYRO 0.00
  • Stochastic Oscillator
  • CGTX 27.88
  • GYRO 84.87

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: